Report Detail
Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Insights, Forecast to 2025
- RnM3021555 |
- 28 February, 2019 |
- Global |
- 125 Pages |
- QYResearch |
- Pharma & Healthcare
The global Post-Polycythemia Vera Myelofibrosis (PPV-MF) market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Post-Polycythemia Vera Myelofibrosis (PPV-MF) market based on company, product type, end user and key regions.
This report studies the global market size of Post-Polycythemia Vera Myelofibrosis (PPV-MF) in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Post-Polycythemia Vera Myelofibrosis (PPV-MF) in these regions.
This research report categorizes the global Post-Polycythemia Vera Myelofibrosis (PPV-MF) market by top players/brands, region, type and end user. This report also studies the global Post-Polycythemia Vera Myelofibrosis (PPV-MF) market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
AbbVie Inc
Celgene Corp
CTI BioPharma Corp
F. Hoffmann-La Roche Ltd
Gilead Sciences Inc
Incyte Corp
Italfarmaco SpA
JW Pharmaceutical Corp
MedImmune LLC
MEI Pharma Inc
Merck & Co Inc
Novartis AG
NS Pharma Inc
Promedior Inc
Sun Pharma Advanced Research Company Ltd
Market size by Product
Durvalumab
Givinostat
Glasdegib
Idelalisib
IMG-7289
Others
Market size by End User
Hospital
Clinic
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Post-Polycythemia Vera Myelofibrosis (PPV-MF) market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Post-Polycythemia Vera Myelofibrosis (PPV-MF) market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Post-Polycythemia Vera Myelofibrosis (PPV-MF) companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Post-Polycythemia Vera Myelofibrosis (PPV-MF) submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Post-Polycythemia Vera Myelofibrosis (PPV-MF) are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Post-Polycythemia Vera Myelofibrosis (PPV-MF) market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Post-Polycythemia Vera Myelofibrosis (PPV-MF) Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size Growth Rate by Product
- 1.4.2 Durvalumab
- 1.4.3 Givinostat
- 1.4.4 Glasdegib
- 1.4.5 Idelalisib
- 1.4.6 IMG-7289
- 1.4.7 Others
- 1.5 Market by End User
- 1.5.1 Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size Growth Rate by End User
- 1.5.2 Hospital
- 1.5.3 Clinic
- 1.5.4 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size
- 2.1.1 Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue 2014-2025
- 2.1.2 Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Sales 2014-2025
- 2.2 Post-Polycythemia Vera Myelofibrosis (PPV-MF) Growth Rate by Regions
- 2.2.1 Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Sales by Regions
- 2.2.2 Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Post-Polycythemia Vera Myelofibrosis (PPV-MF) Sales by Manufacturers
- 3.1.1 Post-Polycythemia Vera Myelofibrosis (PPV-MF) Sales by Manufacturers
- 3.1.2 Post-Polycythemia Vera Myelofibrosis (PPV-MF) Sales Market Share by Manufacturers
- 3.1.3 Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Concentration Ratio (CR5 and HHI)
- 3.2 Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue by Manufacturers
- 3.2.1 Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue by Manufacturers (2014-2019)
- 3.2.2 Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue Share by Manufacturers (2014-2019)
- 3.3 Post-Polycythemia Vera Myelofibrosis (PPV-MF) Price by Manufacturers
- 3.4 Post-Polycythemia Vera Myelofibrosis (PPV-MF) Manufacturing Base Distribution, Product Types
- 3.4.1 Post-Polycythemia Vera Myelofibrosis (PPV-MF) Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Post-Polycythemia Vera Myelofibrosis (PPV-MF) Product Type
- 3.4.3 Date of International Manufacturers Enter into Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Sales by Product
- 4.2 Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue by Product
- 4.3 Post-Polycythemia Vera Myelofibrosis (PPV-MF) Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Breakdown Data by End User
6 North America
- 6.1 North America Post-Polycythemia Vera Myelofibrosis (PPV-MF) by Countries
- 6.1.1 North America Post-Polycythemia Vera Myelofibrosis (PPV-MF) Sales by Countries
- 6.1.2 North America Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Post-Polycythemia Vera Myelofibrosis (PPV-MF) by Product
- 6.3 North America Post-Polycythemia Vera Myelofibrosis (PPV-MF) by End User
7 Europe
- 7.1 Europe Post-Polycythemia Vera Myelofibrosis (PPV-MF) by Countries
- 7.1.1 Europe Post-Polycythemia Vera Myelofibrosis (PPV-MF) Sales by Countries
- 7.1.2 Europe Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Post-Polycythemia Vera Myelofibrosis (PPV-MF) by Product
- 7.3 Europe Post-Polycythemia Vera Myelofibrosis (PPV-MF) by End User
8 Asia Pacific
- 8.1 Asia Pacific Post-Polycythemia Vera Myelofibrosis (PPV-MF) by Countries
- 8.1.1 Asia Pacific Post-Polycythemia Vera Myelofibrosis (PPV-MF) Sales by Countries
- 8.1.2 Asia Pacific Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Post-Polycythemia Vera Myelofibrosis (PPV-MF) by Product
- 8.3 Asia Pacific Post-Polycythemia Vera Myelofibrosis (PPV-MF) by End User
9 Central & South America
- 9.1 Central & South America Post-Polycythemia Vera Myelofibrosis (PPV-MF) by Countries
- 9.1.1 Central & South America Post-Polycythemia Vera Myelofibrosis (PPV-MF) Sales by Countries
- 9.1.2 Central & South America Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Post-Polycythemia Vera Myelofibrosis (PPV-MF) by Product
- 9.3 Central & South America Post-Polycythemia Vera Myelofibrosis (PPV-MF) by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Post-Polycythemia Vera Myelofibrosis (PPV-MF) by Countries
- 10.1.1 Middle East and Africa Post-Polycythemia Vera Myelofibrosis (PPV-MF) Sales by Countries
- 10.1.2 Middle East and Africa Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Post-Polycythemia Vera Myelofibrosis (PPV-MF) by Product
- 10.3 Middle East and Africa Post-Polycythemia Vera Myelofibrosis (PPV-MF) by End User
11 Company Profiles
- 11.1 AbbVie Inc
- 11.1.1 AbbVie Inc Company Details
- 11.1.2 Company Business Overview
- 11.1.3 AbbVie Inc Post-Polycythemia Vera Myelofibrosis (PPV-MF) Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 AbbVie Inc Post-Polycythemia Vera Myelofibrosis (PPV-MF) Products Offered
- 11.1.5 AbbVie Inc Recent Development
- 11.2 Celgene Corp
- 11.2.1 Celgene Corp Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Celgene Corp Post-Polycythemia Vera Myelofibrosis (PPV-MF) Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Celgene Corp Post-Polycythemia Vera Myelofibrosis (PPV-MF) Products Offered
- 11.2.5 Celgene Corp Recent Development
- 11.3 CTI BioPharma Corp
- 11.3.1 CTI BioPharma Corp Company Details
- 11.3.2 Company Business Overview
- 11.3.3 CTI BioPharma Corp Post-Polycythemia Vera Myelofibrosis (PPV-MF) Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 CTI BioPharma Corp Post-Polycythemia Vera Myelofibrosis (PPV-MF) Products Offered
- 11.3.5 CTI BioPharma Corp Recent Development
- 11.4 F. Hoffmann-La Roche Ltd
- 11.4.1 F. Hoffmann-La Roche Ltd Company Details
- 11.4.2 Company Business Overview
- 11.4.3 F. Hoffmann-La Roche Ltd Post-Polycythemia Vera Myelofibrosis (PPV-MF) Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 F. Hoffmann-La Roche Ltd Post-Polycythemia Vera Myelofibrosis (PPV-MF) Products Offered
- 11.4.5 F. Hoffmann-La Roche Ltd Recent Development
- 11.5 Gilead Sciences Inc
- 11.5.1 Gilead Sciences Inc Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Gilead Sciences Inc Post-Polycythemia Vera Myelofibrosis (PPV-MF) Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Gilead Sciences Inc Post-Polycythemia Vera Myelofibrosis (PPV-MF) Products Offered
- 11.5.5 Gilead Sciences Inc Recent Development
- 11.6 Incyte Corp
- 11.6.1 Incyte Corp Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Incyte Corp Post-Polycythemia Vera Myelofibrosis (PPV-MF) Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Incyte Corp Post-Polycythemia Vera Myelofibrosis (PPV-MF) Products Offered
- 11.6.5 Incyte Corp Recent Development
- 11.7 Italfarmaco SpA
- 11.7.1 Italfarmaco SpA Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Italfarmaco SpA Post-Polycythemia Vera Myelofibrosis (PPV-MF) Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Italfarmaco SpA Post-Polycythemia Vera Myelofibrosis (PPV-MF) Products Offered
- 11.7.5 Italfarmaco SpA Recent Development
- 11.8 JW Pharmaceutical Corp
- 11.8.1 JW Pharmaceutical Corp Company Details
- 11.8.2 Company Business Overview
- 11.8.3 JW Pharmaceutical Corp Post-Polycythemia Vera Myelofibrosis (PPV-MF) Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 JW Pharmaceutical Corp Post-Polycythemia Vera Myelofibrosis (PPV-MF) Products Offered
- 11.8.5 JW Pharmaceutical Corp Recent Development
- 11.9 MedImmune LLC
- 11.9.1 MedImmune LLC Company Details
- 11.9.2 Company Business Overview
- 11.9.3 MedImmune LLC Post-Polycythemia Vera Myelofibrosis (PPV-MF) Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 MedImmune LLC Post-Polycythemia Vera Myelofibrosis (PPV-MF) Products Offered
- 11.9.5 MedImmune LLC Recent Development
- 11.10 MEI Pharma Inc
- 11.10.1 MEI Pharma Inc Company Details
- 11.10.2 Company Business Overview
- 11.10.3 MEI Pharma Inc Post-Polycythemia Vera Myelofibrosis (PPV-MF) Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 MEI Pharma Inc Post-Polycythemia Vera Myelofibrosis (PPV-MF) Products Offered
- 11.10.5 MEI Pharma Inc Recent Development
- 11.11 Merck & Co Inc
- 11.12 Novartis AG
- 11.13 NS Pharma Inc
- 11.14 Promedior Inc
- 11.15 Sun Pharma Advanced Research Company Ltd
12 Future Forecast
- 12.1 Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Forecast by Regions
- 12.1.1 Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Sales Forecast by Regions 2019-2025
- 12.1.2 Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue Forecast by Regions 2019-2025
- 12.2 Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Forecast by Product
- 12.2.1 Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Sales Forecast by Product 2019-2025
- 12.2.2 Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue Forecast by Product 2019-2025
- 12.3 Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Forecast by End User
- 12.4 North America Post-Polycythemia Vera Myelofibrosis (PPV-MF) Forecast
- 12.5 Europe Post-Polycythemia Vera Myelofibrosis (PPV-MF) Forecast
- 12.6 Asia Pacific Post-Polycythemia Vera Myelofibrosis (PPV-MF) Forecast
- 12.7 Central & South America Post-Polycythemia Vera Myelofibrosis (PPV-MF) Forecast
- 12.8 Middle East and Africa Post-Polycythemia Vera Myelofibrosis (PPV-MF) Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Post-Polycythemia Vera Myelofibrosis (PPV-MF) Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Post-Polycythemia Vera Myelofibrosis (PPV-MF) . Industry analysis & Market Report on Post-Polycythemia Vera Myelofibrosis (PPV-MF) is a syndicated market report, published as Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Post-Polycythemia Vera Myelofibrosis (PPV-MF) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
